Who is sponsoring NCT03238768?

NCT03238768 is sponsored by University of Minnesota.

What drugs are being tested in NCT03238768?

Interventions in NCT03238768: Enhanced Intravenous Nutrition, Standard Intravenous Nutrition.

What condition does NCT03238768 study?

NCT03238768 studies Preterm Birth.

Is NCT03238768 still recruiting?

NCT03238768 is currently completed. Last updated 29 October 2019.

Last reviewed 2019-10-29 · How we verify

NCT03238768

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Enhanced Nutrition for Preterm Infants

Completed NA Last updated 29 October 2019

What this trial tests

NA trial testing Enhanced Intravenous Nutrition in Preterm Birth in 80 participants. Completed in 31 July 2019.

Timeline

15 August 2017

Primary endpoint
31 July 2019

31 July 2019

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	80
Start date	15 August 2017
Primary completion	31 July 2019
Estimated completion	31 July 2019
Sites	1 location across United States

Drugs / interventions tested

Enhanced Intravenous Nutrition
Standard Intravenous Nutrition

Conditions studied

Preterm Birth — all drugs for Preterm Birth →

Sponsor

University of Minnesota

Who can join

Under 30 Weeks, any sex, with Preterm Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall objective of the proposal is to demonstrate the feasibility of providing increased calories and protein in the first week of life to very low birth weight (VLBW) preterm infants.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

Randomized Trial of Early Enhanced Parenteral Nutrition and Later Neurodevelopment in Preterm Infants.
Morris EE, Miller NC, Marka NA, Super JL, et al · · 2022 · cited 11× · PMID 36235546 · DOI 10.3390/nu14193890
Insulin-like growth factor-1 and insulin-like growth factor binding protein-3 as early predictors of growth, body composition, and neurodevelopment in preterm infants.
Paulsen ME, Marka N, Lunos S, Nagel EM, et al · · 2024 · cited 4× · PMID 38561392 · DOI 10.1038/s41372-024-01933-3
An exploratory study of clinical factors associated with IGF-1 and IGFBP-3 in preterm infants.
Paulsen ME, Marka N, Nagel EM, Gonzalez Villamizar JD, et al · · 2024 · cited 4× · PMID 38191823 · DOI 10.1038/s41390-023-02970-y
Enhanced Parenteral Nutrition Is Feasible and Safe in Very Low Birth Weight Preterm Infants: A Randomized Trial.
Nagel EM, Gonzalez V JD, Bye JK, Super J, et al · · 2023 · cited 4× · PMID 36812894 · DOI 10.1159/000527552
Body composition after implementation of an enhanced parenteral nutrition protocol in the neonatal intensive care unit: a randomised pilot trial.
Nagel EM, Super J, Marka NA, Demerath EW, et al · · 2024 · cited 3× · PMID 38293997 · DOI 10.1080/03014460.2024.2306352

Verify or expand the search:

Other recruiting trials for Preterm Birth

Currently open trials in the same condition.

NCT07265583 — Early Prediction of Lung Injury in Preterm Infants Score · recruiting
NCT07305935 — Comparison of Early Caffeine Administration Vs Supportive Therapy in Preventing Acute Kidney Injury · NA · recruiting
NCT07192393 — Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocoliti · recruiting
NCT06826859 — Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH) · Phase 1, PHASE2 · recruiting
NCT07231432 — Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India · NA · active not recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03238768 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 29 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03238768.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing